{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:20:20Z","timestamp":1774437620139,"version":"3.50.1"},"posted":{"date-parts":[[2025,1,7]]},"group-title":"Neurology","reference-count":50,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,1,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Aneurysmal subarachnoid hemorrhage (aSAH) causes systemic changes that contribute to delayed cerebral ischemia (DCI) and morbidity. Circulating metabolites reflecting underlying pathophysiological mechanisms warrant investigation as biomarker candidates.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Blood samples, prospectively collected within 24 hours (T1) of admission and 7-days (T2) post ictus, from patients with acute aSAH from two tertiary care centers were retrospectively analyzed. Samples from healthy subjects and patients with non-neurologic critical illness served as controls. A validated external analysis platform was used to perform untargeted metabolomics. Bioinformatics analyses were conducted to identify metabolomic profiles defining each group and delineate metabolic pathways altered in each group. Machine learning (ML) models were developed incorporating key metabolites to improve DCI prediction.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 70 aSAH, 30 healthy control, and 17 sick control subjects, a total of 1,117 metabolites were detected. Groups were matched among key clinical variables. DCI occurred in 36% of aSAH subjects, and poor functional outcome was observed in 70% at discharge. Metabolomic profiles readily discriminated the groups. aSAH subjects demonstrated a robust mobilization of lipid metabolites, with increased levels of free fatty acids (FFAs), mono- and diacylglycerols (MAG, DAG) compared with both control groups. aSAH subjects also had decreased circulating amino acid derived metabolites, consistent with increased catabolism. DCI was associated with increased sphingolipids (sphingosine and sphinganine) and decreased acylcarnitines and S- adenosylhomocysteine at T1. Decreased lysophospholipids and acylcarnitines were associated with poor outcomes. Incorporating metabolites into ML models improved prediction of DCI compared with clinical variables alone.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Profound metabolic shifts occur after aSAH with characteristic increases in lipid and decreases in amino acid metabolites. Key lipid metabolites associated with outcomes (sphingolipids, lysophospholipids, and acylcarnitines) provide insight into systemic changes driving secondary complications. These metabolites may also prove to be useful biomarkers to improve prognostication and personalize aSAH care.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.01.06.25320083","type":"posted-content","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:05:37Z","timestamp":1736301937000},"source":"Crossref","is-referenced-by-count":2,"title":["Systemic Metabolic Alterations after Aneurysmal Subarachnoid Hemorrhage: A Plasma Metabolomics Approach"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-3684","authenticated-orcid":false,"given":"Bosco Seong Kyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude P.J.","family":"Savarraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah N.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda L.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folefac D.","family":"Atem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-7774","authenticated-orcid":false,"given":"Philip L.","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefang S.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-9034","authenticated-orcid":false,"given":"Neeraj","family":"Badjatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimahn A.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-6601","authenticated-orcid":false,"given":"Aaron M.","family":"Gusdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025010900351141000_2025.01.06.25320083v1.1","doi-asserted-by":"crossref","unstructured":"Xia C , Hoffman H , Anikpezie N , Philip K , Wee C , Choudhry R , Albright KC , Masoud H , Beutler T , Schmidt E , et al. Trends in the Incidence of Spontaneous Subarachnoid Hemorrhages in the United States, 2007\u20132017. Neurology. 2023;100.","DOI":"10.1212\/WNL.0000000000201340"},{"key":"2025010900351141000_2025.01.06.25320083v1.2","first-page":"54","article-title":"Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association","volume":"2023","year":"2023","journal-title":"Stroke"},{"key":"2025010900351141000_2025.01.06.25320083v1.3","doi-asserted-by":"crossref","unstructured":"Macdonald RL . Origins of the Concept of Vasospasm. Stroke. 2016;47.","DOI":"10.1161\/STROKEAHA.114.006498"},{"key":"2025010900351141000_2025.01.06.25320083v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600283"},{"key":"2025010900351141000_2025.01.06.25320083v1.5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12028-023-01812-3","article-title":"Diagnosis of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage and Triggers for Intervention","volume":"39","year":"2023","journal-title":"Neurocrit Care"},{"key":"2025010900351141000_2025.01.06.25320083v1.6","doi-asserted-by":"publisher","DOI":"10.1161\/hs0901.095677"},{"key":"2025010900351141000_2025.01.06.25320083v1.7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12028-019-00725-4","article-title":"Unruptured Intracranial Aneurysms and SAH CDE Project Investigators. Biospecimens and Molecular and Cellular Biomarkers in Aneurysmal Subarachnoid Hemorrhage Studies: Common Data Elements and Standard Reporting Recommendations","volume":"30","year":"2019","journal-title":"Neurocrit Care"},{"key":"2025010900351141000_2025.01.06.25320083v1.8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12028-022-01546-8","article-title":"Early Systemic Glycolytic Shift After Aneurysmal Subarachnoid Hemorrhage is Associated with Functional Outcomes","volume":"37","year":"2022","journal-title":"Neurocrit Care"},{"key":"2025010900351141000_2025.01.06.25320083v1.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.181610"},{"key":"2025010900351141000_2025.01.06.25320083v1.10","doi-asserted-by":"publisher","DOI":"10.1007\/s007010050457"},{"key":"2025010900351141000_2025.01.06.25320083v1.11","doi-asserted-by":"crossref","unstructured":"Toft-Bertelsen TL , Barbuskaite D , Heerfordt EK , Lolansen SD , Andreassen SN , Rostgaard N , Olsen MH , Norager NH , Capion T , Rath MF , et al. Lysophosphatidic acid as a CSF lipid in posthemorrhagic hydrocephalus that drives CSF accumulation via TRPV4- induced hyperactivation of NKCC1. Fluids Barriers CNS. 2022;19:69.","DOI":"10.1186\/s12987-022-00361-9"},{"key":"2025010900351141000_2025.01.06.25320083v1.12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12975-022-01095-4","article-title":"A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis","volume":"14","year":"2023","journal-title":"Transl Stroke Res"},{"key":"2025010900351141000_2025.01.06.25320083v1.13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12028-020-01138-4","article-title":"Neuromuscular Electrical Stimulation and High-Protein Supplementation After Subarachnoid Hemorrhage: A Single-Center Phase 2 Randomized Clinical Trial","volume":"35","year":"2021","journal-title":"Neurocrit Care"},{"key":"2025010900351141000_2025.01.06.25320083v1.14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.589275"},{"key":"2025010900351141000_2025.01.06.25320083v1.15","doi-asserted-by":"crossref","unstructured":"Fitzgerald KC , Smith MD , Kim S , Sotirchos ES , Kornberg MD , Douglas M , Nourbakhsh B , Graves J , Rattan R , Poisson L , et al. Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism. Cell Rep Med. 2021;2:100424.","DOI":"10.1016\/j.xcrm.2021.100424"},{"key":"2025010900351141000_2025.01.06.25320083v1.16","doi-asserted-by":"crossref","unstructured":"Bhargava P , Fitzgerald KC , Calabresi PA , Mowry EM . Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. JCI Insight. 2017;2.","DOI":"10.1172\/jci.insight.95302"},{"key":"2025010900351141000_2025.01.06.25320083v1.17","first-page":"e1890","article-title":"A prospective study of serum metabolites and risk of ischemic stroke","volume":"92","year":"2019","journal-title":"Neurology"},{"key":"2025010900351141000_2025.01.06.25320083v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-022-00710-w"},{"key":"2025010900351141000_2025.01.06.25320083v1.19","doi-asserted-by":"crossref","unstructured":"Picart-Armada S , Fern\u00e1ndez-Albert F , Vinaixa M , Yanes O , Perera-Lluna A . FELLA: An R package to enrich metabolomics data. BMC Bioinformatics. 2018;19.","DOI":"10.1186\/s12859-018-2487-5"},{"key":"2025010900351141000_2025.01.06.25320083v1.20","doi-asserted-by":"crossref","unstructured":"Bhardwaj R , Nambiar AR , Dutta D . A study of machine learning in healthcare. IEEE 41st Annual Computer Software and Applications Conference (COMPSAC). 2017;236\u2013241.","DOI":"10.1109\/COMPSAC.2017.164"},{"key":"2025010900351141000_2025.01.06.25320083v1.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2005.00503.x"},{"key":"2025010900351141000_2025.01.06.25320083v1.22","doi-asserted-by":"crossref","unstructured":"Chen T , Guestrin C . XGBoost. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New York, NY, USA: ACM; 2016. p. 785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"key":"2025010900351141000_2025.01.06.25320083v1.23","unstructured":"Lundberg S , Lee S-I . A Unified Approach to Interpreting Model Predictions. arXiv preprint. 2017;arXiv:1705.07874."},{"key":"2025010900351141000_2025.01.06.25320083v1.24","doi-asserted-by":"crossref","unstructured":"Chen Y , Galea I , Macdonald RL , Wong GKC , Zhang JH . Rethinking the original changes in subarachnoid haemorrhage: Focusing on real-time metabolism during early brain injury. EBioMedicine. 2022;83.","DOI":"10.1016\/j.ebiom.2022.104223"},{"key":"2025010900351141000_2025.01.06.25320083v1.25","doi-asserted-by":"crossref","first-page":"E1152","DOI":"10.1097\/CCM.0000000000003429","article-title":"Systemic inflammatory response syndrome as predictor of poor outcome in nontraumatic subarachnoid hemorrhage patients","volume":"46","year":"2018","journal-title":"Crit Care Med"},{"key":"2025010900351141000_2025.01.06.25320083v1.26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12028-017-0471-y","article-title":"Early Brain Injury Associated with Systemic Inflammation After Subarachnoid Hemorrhage","volume":"28","year":"2018","journal-title":"Neurocrit Care"},{"key":"2025010900351141000_2025.01.06.25320083v1.27","doi-asserted-by":"crossref","unstructured":"Hellstr\u00f6m S , Sajanti A , Srinath A , Bennett C , Girard R , Jhaveri A , Cao Y , Falter J , Frantz\u00e9n J , Koskim\u00e4ki F , et al. Common lipidomic signatures across distinct acute brain injuries in patient outcome prediction. Neurobiol Dis. 2025;204:106762.","DOI":"10.1016\/j.nbd.2024.106762"},{"key":"2025010900351141000_2025.01.06.25320083v1.28","doi-asserted-by":"crossref","unstructured":"Van Wyngene L , Vandewalle J , Libert C . Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med. 2018;10.","DOI":"10.15252\/emmm.201708712"},{"key":"2025010900351141000_2025.01.06.25320083v1.29","doi-asserted-by":"crossref","unstructured":"Ho WM , G\u00f6rke AS , Glodny B , Oberacher H , Helbok R , Thom\u00e9 C , Petr O . Time Course of Metabolomic Alterations in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage. Front Neurol. 2020;11.","DOI":"10.3389\/fneur.2020.00589"},{"key":"2025010900351141000_2025.01.06.25320083v1.30","doi-asserted-by":"crossref","unstructured":"Li Y , Liu Y , Wu P , Tian Y , Liu B , Wang J , Bihl J , Shi H . Inhibition of Ferroptosis Alleviates Early Brain Injury After Subarachnoid Hemorrhage In Vitro and In Vivo via Reduction of Lipid Peroxidation. Cell Mol Neurobiol [Internet]. 2021 [cited 2024 Jul 26];41:263\u2013278. Available from: https:\/\/link.springer.com\/article\/10.1007\/s10571-020-00850-1","DOI":"10.1007\/s10571-020-00850-1"},{"key":"2025010900351141000_2025.01.06.25320083v1.31","doi-asserted-by":"crossref","unstructured":"Krycer JR , Sharpe LJ , Luu W , Brown AJ . The Akt-SREBP nexus: Cell signaling meets lipid metabolism. Trends in Endocrinology and Metabolism [Internet]. 2010 [cited 2024 Jul 26];21:268\u2013276. Available from: http:\/\/www.cell.com\/article\/S1043276010000032\/fulltext","DOI":"10.1016\/j.tem.2010.01.001"},{"key":"2025010900351141000_2025.01.06.25320083v1.32","doi-asserted-by":"crossref","unstructured":"Ahn S-H , Savarraj JPJ , Parsha K , Hergenroeder GW , Chang TR , Kim DH , Kitagawa RS , Blackburn SL , Choi HA . Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage. J Neuroinflammation [Internet]. 2019;16:213. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31711504","DOI":"10.1186\/s12974-019-1578-1"},{"key":"2025010900351141000_2025.01.06.25320083v1.33","doi-asserted-by":"crossref","unstructured":"Gusdon AM , Savarraj JPJ , Feng D , Starkman A , Li G , Bodanapally U , Zimmerman W , Ryan AS , Choi HA , Badjatia N . Identification of metabolites associated with preserved muscle volume after aneurysmal subarachnoid hemorrhage due to high protein supplementation and neuromuscular electrical stimulation. Sci Rep. 2024;14:15071.","DOI":"10.1038\/s41598-024-64666-5"},{"key":"2025010900351141000_2025.01.06.25320083v1.34","doi-asserted-by":"crossref","unstructured":"Hoppel C. The Role of Carnitine in Normal and Altered Fatty Acid Metabolism. 2003.","DOI":"10.1016\/S0272-6386(03)00112-4"},{"key":"2025010900351141000_2025.01.06.25320083v1.35","doi-asserted-by":"crossref","unstructured":"Seo WK , Jo G , Shin MJ , Oh K . Medium-chain acylcarnitines are associated with cardioembolic stroke and stroke recurrence a metabolomics study. Arterioscler Thromb Vasc Biol [Internet]. 2018 [cited 2024 Jul 28];38:2245\u20132253. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/ATVBAHA.118.311373","DOI":"10.1161\/ATVBAHA.118.311373"},{"key":"2025010900351141000_2025.01.06.25320083v1.36","doi-asserted-by":"crossref","unstructured":"Lee SGW , Ro YS , Jung E , Moon SB , Park GJ , Yoon H , Park JH , Shin S Do . Serum Acylcarnitine and Long-Term Functional Prognosis after Traumatic Brain Injury with Intracranial Injury: A Multi-Center Prospective Study. https:\/\/home.liebertpub.com\/neu [Internet]. 2023 [cited 2024 Jul 28];40:274\u2013282. Available from: https:\/\/www.liebertpub.com\/doi\/10.1089\/neu.2022.0096","DOI":"10.1089\/neu.2022.0096"},{"key":"2025010900351141000_2025.01.06.25320083v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.129"},{"key":"2025010900351141000_2025.01.06.25320083v1.38","doi-asserted-by":"crossref","unstructured":"Resitoglu G , Akgun MY , Ates O , Oztanir MN . Investigation of the effect of carnitine on cerebral vasospasm in experimental subarachnoid hemorrhage model. Sci Rep. 2023;13.","DOI":"10.1038\/s41598-023-50025-3"},{"key":"2025010900351141000_2025.01.06.25320083v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27838-9"},{"key":"2025010900351141000_2025.01.06.25320083v1.40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/neu.2023.0046","article-title":"Lysophospholipids Are Associated With Outcomes in Hospitalized Patients With Mild Traumatic Brain Injury","volume":"41","year":"2024","journal-title":"J Neurotrauma"},{"key":"2025010900351141000_2025.01.06.25320083v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvt048"},{"key":"2025010900351141000_2025.01.06.25320083v1.42","doi-asserted-by":"crossref","unstructured":"Jiang S , Yang H , Li M . Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases. Int J Mol Sci. 2023;24:12524.","DOI":"10.3390\/ijms241512524"},{"key":"2025010900351141000_2025.01.06.25320083v1.43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.1302831","article-title":"The Autotaxin\u2013LPA Axis Emerges as a Novel Regulator of Lymphocyte Homing and Inflammation","volume":"192","year":"2014","journal-title":"The Journal of Immunology"},{"key":"2025010900351141000_2025.01.06.25320083v1.44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12975-023-01133-9","article-title":"Sphingosine-1-phosphate Signalling in Aneurysmal Subarachnoid Haemorrhage: Basic Science to Clinical Translation","volume":"15","year":"2024","journal-title":"Transl Stroke Res"},{"key":"2025010900351141000_2025.01.06.25320083v1.45","doi-asserted-by":"crossref","unstructured":"Jackson CM , Choi J , Routkevitch D , Pant A , Saleh L , Ye X , Caplan JM , Huang J , McDougall CG , Pardoll DM , et al. PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage. Neurosurgery [Internet]. 2020;Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33370819","DOI":"10.1093\/neuros\/nyaa495"},{"key":"2025010900351141000_2025.01.06.25320083v1.46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-743757"},{"key":"2025010900351141000_2025.01.06.25320083v1.47","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00544.2007"},{"key":"2025010900351141000_2025.01.06.25320083v1.48","first-page":"e553","article-title":"Machine Learning to Predict Delayed Cerebral Ischemia and Outcomes in Subarachnoid Hemorrhage","volume":"96","year":"2021","journal-title":"Neurology"},{"key":"2025010900351141000_2025.01.06.25320083v1.49","doi-asserted-by":"crossref","unstructured":"Taghavi RM , Zhu G , Wintermark M , Kuraitis GM , Sussman ES , Pulli B , Biniam B , Ostmeier S , Steinberg GK , Heit JJ . Prediction of delayed cerebral ischemia after cerebral aneurysm rupture using explainable machine learning approach. Interventional Neuroradiology. 2023; 0(0).","DOI":"10.1177\/15910199231170411"},{"key":"2025010900351141000_2025.01.06.25320083v1.50","doi-asserted-by":"crossref","unstructured":"Loscalzo J . Redox Dysregulation in Vascular Pathobiology. Free Radic Biol Med. 2014;75:S2.","DOI":"10.1016\/j.freeradbiomed.2014.10.597"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.01.06.25320083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:24:42Z","timestamp":1768508682000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.01.06.25320083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1101\/2025.01.06.25320083","relation":{},"subject":[],"published":{"date-parts":[[2025,1,7]]},"subtype":"preprint"}}